🚨 $TMDX Q2 EARNINGS 🚨 • Sales $157M vs Est. $148M • EPS $0.92 vs Est. $0.45 • Net Income $35M vs Est. $17M FY25 Guidance • Sales $595M vs Est. $582M Received FDA approval for next-gen lung trial
Show original
50.94K
348
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.